The immune system and neuropsychiatric diseases

International Review of Psychiatry

Volumn 17, Issue 6, 2005, Pages 443-449

  Kerr, Douglas ^a,b   Krishnan, Chitra ^a   Pucak, Michele L ^a,c   Carmen, Jessica ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FAS LIGAND; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

B LYMPHOCYTE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; MACROPHAGE; MENTAL DISEASE; MICROGLIA; NEUROENDOCRINE SYSTEM; NEUROPSYCHIATRY; PERIPHERAL NERVOUS SYSTEM; PHAGOCYTE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TRANSGENIC MOUSE; VAGUS NERVE;

BRAIN; CYTOKINES; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNITY, NATURAL; INFECTION; NEOPLASMS; NERVOUS SYSTEM; NEUROSECRETORY SYSTEMS; PSYCHONEUROIMMUNOLOGY; VAGUS NERVE;

EID: 30644470964     PISSN: 09540261     EISSN: None     Source Type: Journal    
DOI: 10.1080/0264830500381435     Document Type: Review

References (55)

1. Abbott, N. J. (2000). Inflammatory mediators and modulation of blood-brain barrier permeability. Cell & Molecular Neurobiology, 20(2), 131-147.
2. Abramson, S. B., Amin, A. R., Clancy, R. M., & Attur, M. (2001). The role of nitric oxide in tissue destruction. Best Practice Research in Clinical Rheumatology, 15(5), 831-845.
3. Aloisi, F., Care, A., Borsellino, G., Gallo, P., Rosa, S., Bassani, A., et al. (1992). Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. Journal Immunology, 149(7), 2358-2366.
4. Anisman, H., & Merali, Z. (2002). Cytokines, stress, and depressive illness. Brain, Behaviour & Immunity, 16(5), 513-524.
5. Anisman, H., Merali, Z., Poulter, M. O., & Hayley, S. (2005). Cytokines as a precipitant of depressive illness: animal and human studies. Current Pharmaceutical Design, 11(8), 963-972.
6. Avolio, C., Giuliani, F., Liuzzi, G. M., Ruggieri, M., Paolicelli, D., Riccio, P., et al. (2003). Adhesion molecules and matrix metalloproteinases in multiple sclerosis: Effects induced by Interferon-beta. Brain Research Bulletin, 61(3), 357-364.
7. Banks, W. A., Kastin, A. J., & Broadwell, R. D. (1995). Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation, 2(4), 241-248.
8. Barde, Y. A. (1994). Neurotrophins: A family of proteins supporting the survival of neurons. Progress in Clinical & Biological Research, 390, 45-56.
9. Besedovsky, H., del Rey, A., Sorkin, E., & Dinarello, C. A. (1986). Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science, 233(4764), 652-654.
10. Blantz, R. C., & Munger, K. (2002). Role of nitric oxide in inflammatory conditions. Nephron, 90(4), 373-378.
11. Bluthe, R. M., Michaud, B., Kelley, K. W., & Dantzer, R. (1996). Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally. NeuroReport, 7(9), 1485-1488.
12. Brundula, V., Rewcastle, N. B., Metz, L. M., Bernard, C. C., & Yong, V. W. (2002). Targeting leukocyte MMPs and transmigration: Minocycline as a potential therapy for multiple sclerosis. Brain, 125(Pt 6), 1297-1308.
13. Capuron, L., Raison, C. L., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., & Miller, A. H. (2003). Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. American Journal of Psychiatry, 160(7), 1342-1345.
14. Comoletti, D., Muzio, V., Capobianco, A., Ravizza, T., & Mennini, T. (2001). Nitric oxide produced by non-motoneuron cells enhances rat embryonic motoneuron sensitivity to excitotoxins: comparison in mixed neuron/glia or purified cultures. Journal of Neurological Sciences, 192(1-2), 61-69.
15. Correale, J., & Villa, A. (2004). The neuroprotective role of inflammation in nervous system injuries. Journal of Neurology, 251(11), 1304-1316.
16. Corriveau, R. A., Huh, G. S., & Shatz, C. J. (1998). Regulation of class I MHC gene expression in the developing and mature CNS by neural activity. Neuron, 21(3), 505-520.
17. De Simone, R., Levi, G., & Aloisi, F. (1998). Interferon gamma gene expression in rat central nervous system glial cells. Cytokine, 10(6), 418-422.
18. Dell'Albani, P., Santangelo, R., Torrisi, L., Nicoletti, V. G., & Giuffrida Stella, A. M. (2003). Role of the JAK/STAT signal transduction pathway in the regulation of gene expression in CNS. Neurochemical Research, 28(1), 53-64.
19. Denicoff, K. D., Durkin, T. M., Lotze, M. T., Quinlan, P. E., Davis, C. L., Listwak, S. J., et al. (1989). The neuroendocrine effects of interleukin-2 treatment. Journal of Clinical Endocrinology & Metabolism, 69(2), 402-410.
20. Dunn, A. J. (2000). Cytokine activation of the HPA axis. Annals of the New York Academy of Sciences, 917, 608-617.
21. Ehrhard, P. B., Erb, P., Graumann, U., & Otten, U. (1993). Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. Proceedings of the National Academy of Science USA, 90(23), 10984-10988.
22. Esposito, P., Gheorghe, D., Kandere, K., Pang, X., Connolly, R., Jacobson, S., et al. (2001). Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Research, 888(1), 117-127.
23. Friedman, B., Kleinfeld, D., Ip, N. Y., Verge, V. M., Moulton, R., Boland, P., et al. (1995). BDNF and NT-4/5 exert neurotrophic influences on injured adult spinal motor neurons. Journal of Neuroscience, 15(2), 1044-1056.
24. Gadient, R. A., & Otten, U. H. (1997). Interleukin-6 (IL-6) - a molecule with both beneficial and destructive potentials. Progress in Neurobiology, 52(5), 379-390.
25. Gloor, S. M., Wachtel, M., Bolliger, M. F., Ishihara, H., Landmann, R., & Frei, K. (2001). Molecular and cellular permeability control at the blood-brain barrier. Brain Research. Brain Research Reviews, 36(2-3), 258-264.
26. Gruol, D. L., & Nelson, T. E. (1997). Physiological and pathological roles of interleukin-6 in the central nervous system. Molecular Neurobiology, 15(3), 307-339.
27. Guillemin, G. J., & Brew, B. J. (2004). Microglia, macrophages, perivascular macrophages, and pericytes: A review of function and identification. Journal of Leukocyte Biology, 75(3), 388-397.
28. Hanisch, U. K., Rowe, W., van Rossum, D., Meaney, M. J., & Quirion, R. (1996). Phasic hyperactivity of the HPA axis resulting from chronic central IL-2 administration. NeuroReport, 7(18), 2883-2888.
29. Harbuz, M. S., Stephanou, A., Sarlis, N., & Lightman, S. L. (1992). The effects of recombinant human interleukin (IL)-1 alpha, IL-1 beta or IL-6 on hypothalamo-pituitary-adrenal axis activation. Journal of Endocrinology, 133(3), 349-355.
30. Hayley, S., Brebner, K., Lacosta, S., Merali, Z., & Anisman, H. (1999). Sensitization to the effects of tumor necrosis factor-alpha: Neuroendocrine, central monoamine, and behavioral variations. Journal of Neuroscience, 19(13), 5654-5665.
31. Isaksson, J., Farooque, M., & Olsson, Y. (2005). Improved functional outcome after spinal cord injury in iNOS-deficient mice. Spinal Cord, 43(3), 167-170.
32. Kaplin, A. I., Deshpande, D. M., Scott, E., Krishnan, C., Carmen, J. S., Shats, I., et al. (2005). IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. Journal of Clinical Investigation, 115(10), 2731-2741.
33. Licinio, J., Prolo, P., McCann, S. M., & Wong, M. L. (1999). Brain iNOS: Current understanding and clinical implications. Molecular Medicine Today, 5(5), 225-232.
34. 2- microglobulin in rat spinal motoneurons: Regulatory influences by IFN-gamma and axotomy. Experimental Neurology, 150(2), 282-295.
35. 2-microglobulin in rat brainstem motoneurons and nigral dopaminergic neurons. Journal of Neuroimmunology, 101(1), 76-86.
36. Linthorst, A. C., Flachskamm, C., Holsboer, F., & Reul, J. M. (1994). Local administration of recombinant human interleukin-1 beta in the rat hippocampus increases serotonergic neurotransmission, hypothalamic-pituitary- adrenocortical axis activity, and body temperature. Endocrinology, 135(2), 520-532.
37. Merrill, J. E., & Murphy, S. P. (1997). Inflammatory events at the blood brain barrier: Regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species. Brain, Behaviour & Immunity, 11(4), 245-263.
38. Milatovic, D., Gupta, R. C., & Dettbarn, W. D. (2002). Involvement of nitric oxide in kainic acid-induced excitotoxicity in rat brain. Brain Research, 957(2), 330-337.
39. Moalem, G., Monsonego, A., Shani, Y., Cohen, I. R., & Schwartz, M. (1999). Differential T cell response in central and peripheral nerve injury: Connection with immune privilege. The FASEB journal: Official publication of the Federation of American Societies for Experimental Biology, 13(10), 1207-1217.
40. Paul, R., Lorenzl, S., Koedel, U., Sporer, B., Vogel, U., Frosch, M., et al. (1998). Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Annals of Neurology, 44(4), 592-600.
41. Rock, F. L., Hardiman, G., Timans, J. C., Kastelein, R. A., & Bazan, J. F. (1998). A family of human receptors structurally related to Drosophila Toll. Proceedings of the National Academy of Science USA, 95(2), 588-593.
42. Rothwell, N. J., Luheshi, G., & Toulmond, S. (1996). Cytokines and their receptors in the central nervous system: Physiology, pharmacology, and pathology. Pharmacology & Therapeutics, 69(2), 85-95.
43. Sapolsky, R., Rivier, C., Yamamoto, G., Plotsky, P., & Vale, W. (1987). Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science, 238(4826), 522-524.
44. Schwartz, M., & Moalem, G. (2001). Beneficial immune activity after CNS injury: Prospects for vaccination. Journal of Neuroimmunology, 113(2), 185-192.
45. Simard, A. R., & Rivest, S. (2004). Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia. The FASEB journal: Official publication of the Federation of American Societies for Experimental Biology, 18(9), 998-1000.
46. Tikka, T. M., & Koistinaho, J. E. (2001). Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. Journal of Immunology, 166(12), 7527-7533.
47. Tonelli, L. H., Postolache, T. T., & Sternberg, E. M. (2005). Inflammatory genes and neural activity: involvement of immune genes in synaptic function and behavior. Frontiers in bioscience: A journal and virtual library, 10, 675-680.
48. van den Borne, B. E., Dijkmans, B. A., de Rooij, H. H., le Cessie, S., & Verweij, C. L. (1997). Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells. Journal of Rheumatology, 24(1), 55-60.
49. van Landeghem, F. K., Stover, J. F., Bechmann, I., Bruck, W., Unterberg, A., Buhrer, C., et al. (2001). Early expression of glutamate transporter proteins in ramified microglia after controlled cortical impact injury in the rat. Glia, 35(3), 167-179.
50. Wang, J., & Dunn, A. J. (1998). Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism. Neurochemistry International, 33(2), 143-154.
51. Watkins, L. R., Maier, S. F., & Goehler, L. E. (1995). Cytokine-to-brain communication: a review & analysis of alternative mechanisms. Life Sciences, 57(11), 1011-1026.
52. Wilbanks, G. A., & Streilein, J. W. (1992). Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta. European Journal of Immunology, 22(4), 1031-1036.
53. Wilson, C. J., Finch, C. E., & Cohen, H. J. (2002). Cytokines and cognition - the case for a head-to-toe inflammatory paradigm. Journal of the American Geriatric Society, 50(12), 2041-2056.
54. Yrjanheikki, J., Keinanen, R., Pellikka, M., Hokfelt, T., & Koistinaho, J. (1998). Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proceedings of the National Academy of Science USA, 95(26), 15769-15774.
55. Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y., Ona, V., Li, M., et al. (2002). Minocycline inhibits cytochrome C release and delays progression of amyotrophic lateral sclerosis in mice. Nature, 417(6884), 74-78.